Maxim Soloviev

Executive Director, Toxicology at Incyte

Role: Executive Director, Toxicology at Incyte
Location: Wilmington, DE, US
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

Experience

Executive Director, Toxicology
Incyte
Feb 2024 — Present · Wilmington, DE, US
Pre-clinical development: Design, placement, management, and reporting of toxicology and safety pharmacology studies (internally and at contract research organizations)responsible for toxicology and safety pharmacology studies * In-house expertise for safety pharmacology studies needed to support preclinical and clinical development, author regulatory submissions related to same;* Assessment of cardiovascular data obtained in clinical trials* Interpretation and reporting study data to internal and external working groups including the clinical development team* Preparation of the reports and documents for nomination and regulatory submissions* Preparation of toxicology and safety pharmacology sections for IND and NDA submissions* Toxicological support for clinical studies

Education

Pavlov Medical University of St. Petersburg
PhD, Surgery, Cardiology, and Metabolic Diseases
1989 — 1992
Pavlov Medical University of St. Petersburg
MD, Medicine
1981 — 1987

Skills

Toxicology
CRO Management
Adme
Ind
Clinical Study Design
U.s. Food and Drug Administration (Fda)
Biomarkers
CRO
Cardiology
Translational Medicine
Good Laboratory Practice (Glp)
Drug Discovery
Pharmacokinetics
Life Sciences
Regulatory Affairs
Lifesciences
R&D
Physiology
Oncology
Glp
Translational Research
Pharmacology
Drug Development
Nda
Bioanalysis
Clinical Trials
Dmpk
Biotechnology
Research and Development (R&D)
Safety Pharmacology
Regulatory Submissions
In Vivo
Immunology
Assay Development
Pharmaceutical Industry
Sop
Fda
Animal Models
In Vitro
Drug Metabolism

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
m••••••••@incyte.com
Personal email
•••••@•••••.com
Direct dial
+18•••••••64

Unlock verified contacts

Free to start · No credit card required

Current company

Incyte

Pharmaceutical Manufacturing · 3.5K employees · Wilmington, Delaware, United States

Incyte is focused on advancing biopharmaceutical innovation. Founded in 2002 with a small number of scientists, chemists and biologists in Wilmington, Delaware, Incyte has grown into a global organization with a robust portfolio of treatments across Hematology, Oncology and Inflammation and Autoimmunity. Today, the company has more than 2,800 employees and operations in 13 countries across North America, Europe and Asia. Our goal is to develop breakthrough medicines that improve patients' lives. With patients at the center of everything we do, our discovery approach focuses on building a portfolio of compounds that are scientifically differentiated and poised to make a meaningful impact. At Incyte, we aim to foster a workplace grounded in respect, curiosity and accountability. We are proud to have been named among the Top Employers by Science magazine for 8 consecutive years, as well as being named one of the Global Top 100 Most Loved Workplaces and America’s Top 100 Most Loved Workplaces by Newsweek and the Best Practice Institute. To learn more, visit Incyte.com and Investor.Incyte.com. Follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube. See our Community Guidelines: http://bit.ly/2sV0H5W

incyte.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Executive Director, Toxicology

Education

Pavlov Medical University of St. Petersburg

Pavlov Medical University of St. Petersburg

Skills

Find verified contacts for anyone on LinkedIn